VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,003 | -58.2% | 57,871 | -36.2% | 0.00% | -50.0% |
| Q2 2023 | $597,647 | -3.3% | 90,690 | -0.4% | 0.00% | 0.0% |
| Q1 2023 | $618,236 | +57.1% | 91,051 | +71.0% | 0.00% | +100.0% |
| Q4 2022 | $393,599 | -29.7% | 53,261 | -6.1% | 0.00% | -50.0% |
| Q3 2022 | $560,000 | -14.0% | 56,730 | -5.0% | 0.00% | 0.0% |
| Q2 2022 | $651,000 | -20.5% | 59,685 | -17.6% | 0.00% | 0.0% |
| Q1 2022 | $819,000 | -27.9% | 72,400 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,136,000 | -8.5% | 72,400 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $1,241,000 | -20.3% | 72,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,557,000 | +43.2% | 72,400 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $1,087,000 | +7.8% | 72,400 | -5.6% | 0.00% | 0.0% |
| Q4 2020 | $1,008,000 | +21.0% | 76,700 | -11.0% | 0.00% | 0.0% |
| Q3 2020 | $833,000 | -18.6% | 86,200 | -3.6% | 0.00% | -33.3% |
| Q2 2020 | $1,023,000 | +10.8% | 89,400 | +0.3% | 0.00% | 0.0% |
| Q1 2020 | $923,000 | -28.0% | 89,100 | +14.1% | 0.00% | 0.0% |
| Q4 2019 | $1,282,000 | +23.6% | 78,100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,037,000 | -1.5% | 78,100 | +4.6% | 0.00% | 0.0% |
| Q2 2019 | $1,053,000 | -21.7% | 74,700 | +2.2% | 0.00% | -25.0% |
| Q1 2019 | $1,345,000 | -2.3% | 73,100 | +38.7% | 0.00% | 0.0% |
| Q4 2018 | $1,377,000 | +14.8% | 52,700 | +0.8% | 0.00% | +33.3% |
| Q3 2018 | $1,200,000 | +20.5% | 52,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $996,000 | +79.1% | 52,300 | +58.5% | 0.00% | +50.0% |
| Q1 2018 | $556,000 | +10.8% | 33,000 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $502,000 | -15.1% | 33,000 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $591,000 | +9.9% | 33,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $538,000 | – | 33,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |